# CELLYAN BIOTECHNOLOGY CO LTD ORD SHS CL A

CELLYAN BIOTECHNOLOGY CO LTD ORD SHS CL A is a security (CUSIP G6365B104) tracked across SEC portfolio filings. 6 institutional managers reported $51K on Form 13F as of 2026-03-31.

## Summary

- Issuer: CELLYAN BIOTECHNOLOGY CO LTD
- Class: ORD SHS CL A
- CUSIP: G6365B104
- 13F holders: 6
- 13F value: $51K
- 13F period: 2026-03-31
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| StoneX Group Inc. | New York, NY | $22K | 39,395 |
| [CLEAR STREET LLC](https://search.stillhousedata.com/firm/288933) | NEW YORK, NY | $15K | 12,019 |
| Clear Street Group Inc. | NEW YORK, NY | $7K | 12,019 |
| [TWO SIGMA INVESTMENTS, LP](https://search.stillhousedata.com/firm/137137) | New York, NY | $6K | 10,832 |
| UBS Group AG | Zurich, V8 | $63 | 110 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/G6365B104.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.